RopesTalk

In this episode of There Has to Be a Better Way?, co-hosts Zach Coseglia and Hui Chen interview their colleague David Yanofsky, a former award-winning data journalist who joined R&G Insights Lab as manager of data visualization. David shares how he finds stories in data and uses them to help companies achieve their goals and live up to their ideals.

In the latest installment of Ropes & Gray’s Alumni @ RopesTalk podcast, strategic transactions partner Abby Gregor interviews Beibei Sun, senior corporate counsel of global licensing and business development at Sanofi. Beibei was an associate in the life sciences group at Ropes & Gray before joining Sanofi in 2021. At Sanofi, she supports the specialty care business unit on licensing transactions and the ventures team on venture capital transactions. In this interview, Beibei talks about the differences between being a deal lawyer at a big firm versus in-house. In thinking about her career, she shares the three pieces of advice she would give to newer lawyers. Beibei also reflects on her time at Ropes & Gray—what she gained from the firm, what she misses most, and how she’s been able to continue doing pro bono work in collaboration with the firm as an alumni. 

Tune in to the second episode of Ropes & Gray's podcast series The Data Day, brought to you by the firm’s data, privacy & cybersecurity practice. This series focuses on the day-to-day effects that data has on all of our lives as well as other exciting and interesting legal and regulatory developments in the world of data, and will feature a range of guests, including clients, regulators and colleagues. On this episode, hosts Fran Faircloth, a partner in Ropes & Gray's Washington, D.C. office, and Edward Machin, a London-based associate, discuss recent enforcement by the California Attorney General, including a new round of enforcement sweeps, actions by the California Privacy Protection Agency, and the relationship between the California Consumer Privacy Act (CCPA) and the California Privacy Rights Act (CPRA). 

In this episode of Women @ RopesTalk, hosted by IP transactions partner Megan Baca, M&A partner Emily Oldshue speaks with Siobhan Pomeroy, vice president of corporate development at leading biopharmaceutical company Gilead Sciences. With a background in science and an MBA, Siobhan talks about the many business and corporate development roles she’s held across the life sciences industry, including at a medical device firm, smaller biotech companies and larger pharmaceutical companies. She plots her trajectory to her current role as a leader of transaction teams and gives her invaluable perspective on team building. Thinking about her career, she remembers a deal where her personal and professional lives collided, and shares the advice she gives to women colleagues who ask her about work-life balance.

Join Ropes & Gray’s life sciences and health care attorneys on a four-part podcast series exploring regulatory, compliance and enforcement changes emanating from Washington, D.C. and the potential impact on life sciences companies in 2023. This fourth episode will feature a lightning round where we cover additional insights on expected developments not covered earlier in the series. Topics discussed include anticipated guidance on drug compounding, advertising and promotion, the redesign of the Human Foods Program, and more.

Co-hosts Zach Coseglia and Hui Chen explore the power of storytelling with Megan Zwiebel, the “untangler of knots” and director of operations and delivery at R&G Insights Lab, who went from working as a litigation attorney to anti-corruption journalist, and now as the person who makes the trains run on time at the Insights Lab. Along the way, she shares insights about uncovering juicy fact patterns in corruption cases, the need for organizations to take narrative control of their identities, and the human beings who read legal briefs.

In this Ropes & Gray podcast, asset management partners Jason Kolman and Jessica Marlin discuss the latest market trends in rated note structures. They discuss how these feeders into private credit funds respond to regulatory capital preferences of insurance company investors, key differences compared to traditional fund structures, the latest terms in the market, and navigating the ratings agency process. 

Join Ropes & Gray’s life sciences and health care attorneys on a four-part podcast series exploring regulatory, compliance and enforcement changes emanating from Washington, D.C. and the potential impact on life sciences companies in 2023. This third episode will focus on what we except to see in the courts throughout 2023. Topics discussed include litigation challenges against the agencies, enforcement litigation by the government and other matters.

Join Ropes & Gray’s life sciences and health care attorneys on a four-part podcast series exploring regulatory, compliance and enforcement changes emanating from Washington, D.C. and the potential impact on life sciences companies in 2023. This second episode will focus on anticipated policy developments from FDA and CMS in 2023. Topics discussed include rulemaking implications of the Food and Drug Omnibus Reform Act (FDORA), accelerated approval reform, potential digital health device and cybersecurity guidance, the end of the public health emergency, the Inflation Reduction Act, Part D reforms, and CMMI and HRSA action around the 340B program.

In this Ropes & Gray podcast, asset management partners Nicole Krea and Joel Wattenbarger discuss three recent headline items in regulatory compliance for private funds: first, the new marketing rule FAQ, with respect to extracted performance; second, the recently released Regulatory Flex Agenda; and, third, the SEC's 2023 exam priorities. The Private Fund Regulatory Update is a series of podcasts discussing key issues of interest and updates in the regulatory and compliance space, focusing in particular on private fund managers.